{"id":"W4401913715","doi":"10.1002/hem3.146","title":"Long‐term immune changes in patients with relapsed/refractory chronic lymphocytic leukemia following treatment with venetoclax plus rituximab","year":2024,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Genentech; F. Hoffmann-La Roche; AbbVie","keywords":"Rituximab; Hypogammaglobulinemia; Medicine; Internal medicine; Chronic lymphocytic leukemia; CD20; Gastroenterology; Venetoclax; Refractory (planetary science); Antibody; Immune system; Immunology; Bendamustine; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001723016,0.0005525552,0.0008627923,0.0002175571,0.0001047229,0.00009772523,0.0002044969,0.0002470552,0.0005245681],"category_scores_gemma":[0.00002215195,0.0003739627,0.0001730264,0.0007340726,0.0001641736,0.0002285964,0.00009745519,0.0004117285,0.0003058441],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.4106811,"about_ca_system_score_gemma":0.06669948,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002576682,"about_ca_topic_score_gemma":0.002894151,"domain_scores_codex":[0.9966741,0.00006731395,0.0004027706,0.0008815069,0.0009666551,0.001007722],"domain_scores_gemma":[0.9984627,0.000162808,0.00008080688,0.0009157386,0.00007947517,0.0002984552],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.05933584,0.00380282,0.1860128,0.03383659,0.01676237,0.1492266,0.02246398,0.01648017,0.005458679,0.0005552728,0.003421266,0.5026436],"study_design_scores_gemma":[0.6930832,0.04768706,0.1003122,0.03576162,0.002731553,0.001692595,0.0008841493,0.08285441,0.01248826,0.00003868931,0.01894869,0.003517636],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9774057,0.01852078,0.00004001884,0.00005780497,0.0002446351,0.00167362,0.00001128514,0.0002679124,0.001778198],"genre_scores_gemma":[0.9929657,0.0004360894,0.0001867506,0.00005425636,0.0002531977,0.0003399459,0.0001661027,0.0001888947,0.005409091],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6337473,"threshold_uncertainty_score":0.9998713,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01191090679989695,"score_gpt":0.264676162737068,"score_spread":0.2527652559371711,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}